Pyrroloquinoline quinone alleviates oxidative damage induced by high glucose in HepG2 cells.

Abstract

Hyperglycemia as a common metabolic disorder in diabetes led to oxidative stress, inflammation and other complications. Natural and manufactured antioxidants alleviates the side effects of diabetes. The purpose of current study is to investigate the effect of pyrroloquinoline quinine (PQQ) as an antioxidant on the content of glucose-induced oxidative stress generation in the cells of the human hepatocellular liver carcinoma (HepG2) by inhibiting advanced glycation end products (AGEs) formation. The HepG2 cells were exposed to high dose (50 mM) of glucose (HG) only and with PQQ (HG + PQQ). Treatment with high dose increased AGEs formation, expression of receptor for advanced glycation endproducts (RAGE), reactive oxygen species ROS production, and oxidative stress markers in treated HepG2 cells. Interestingly, PQQ significantly reduced AGEs formation and (RAGE) expression, ROS formation, and inflammation induced by glucose. In conclusion, PQQ has a potentiail role as an antioxidant to reduce the oxidative damage during hyperglycemia by AGEs inhibition.

• Authors: Saad Alkahtani, Saud Alarifi, Abdullah A Alkahtane, Gadah Albasher, Mohammed Al-Zharani, Norah M Alhoshani, Norah S Al-Johani, Nada H Aljarba, Md Saquib Hasnain
• Journal: Saudi journal of biological sciences (Saudi J Biol Sci) Vol. 28 Issue 11 Pg. 6127-6132 (Nov 2021) ISSN: 1319-562X [Print] Saudi Arabia
• PMID: 34759737 (Publication Type: Journal Article)
• Copyright: © 2021 The Author(s).